Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hollenbaugh

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Current Opinion in Immunology|October 26, 2001
Therapeutic intervention with inhibitors of co-stimulatory pathways in autoimmune diseaseA Aruffo, D Hollenbaugh
Current Opinion in Immunology|April 1, 1992
Recombinant globulins: novel research tools and possible pharmaceuticalsD Hollenbaugh, N J Chalupny, A Aruffo
Biochemistry|April 25, 1995
Effects of chemical modification on the binding activities of P-selectin mutantsD Hollenbaugh, A Aruffo, P D Senter
Research in Immunology|March 1, 1994
The role of CD40L (gp39)/CD40 in T/B cell interaction and primary immunodeficiencyH D Ochs, D Hollenbaugh, A Aruffo
Seminars in Immunology|October 1, 1994
The role of CD40L (gp39)/CD40 in T/B cell interaction and primary immunodeficiencyH D Ochs, D Hollenbaugh, A Aruffo
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Cutting edge: CD40 ligand is a limiting factor in the humoral response to T cell-dependent antigensM Pérez-Melgosa, D Hollenbaugh, C B Wilson
Journal of Immunological Methods|December 15, 1995
Cleavable CD40Ig fusion proteins and the binding to sgp39D Hollenbaugh, J Douthwright, V McDonald, et al.
Current Protocols in Immunology|April 25, 2008
Use of monoclonal antibodies for expression cloningD Hollenbaugh, A Aruffo, B Jones, et al.
Biochemistry|March 30, 1993
Interaction of P-selectin (CD62) and its cellular ligand: analysis of critical residuesD Hollenbaugh, J Bajorath, R Stenkamp, et al.
The Journal of Cell Biology|July 1, 1993
Identification of hyaluronic acid binding sites in the extracellular domain of CD44R J Peach, D Hollenbaugh, I Stamenkovic, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Current Opinion in Immunology|October 26, 2001
Therapeutic intervention with inhibitors of co-stimulatory pathways in autoimmune diseaseA Aruffo, D Hollenbaugh
Current Opinion in Immunology|April 1, 1992
Recombinant globulins: novel research tools and possible pharmaceuticalsD Hollenbaugh, N J Chalupny, A Aruffo
Biochemistry|April 25, 1995
Effects of chemical modification on the binding activities of P-selectin mutantsD Hollenbaugh, A Aruffo, P D Senter
Research in Immunology|March 1, 1994
The role of CD40L (gp39)/CD40 in T/B cell interaction and primary immunodeficiencyH D Ochs, D Hollenbaugh, A Aruffo
Seminars in Immunology|October 1, 1994
The role of CD40L (gp39)/CD40 in T/B cell interaction and primary immunodeficiencyH D Ochs, D Hollenbaugh, A Aruffo
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Cutting edge: CD40 ligand is a limiting factor in the humoral response to T cell-dependent antigensM Pérez-Melgosa, D Hollenbaugh, C B Wilson
Journal of Immunological Methods|December 15, 1995
Cleavable CD40Ig fusion proteins and the binding to sgp39D Hollenbaugh, J Douthwright, V McDonald, et al.
Current Protocols in Immunology|April 25, 2008
Use of monoclonal antibodies for expression cloningD Hollenbaugh, A Aruffo, B Jones, et al.
Biochemistry|March 30, 1993
Interaction of P-selectin (CD62) and its cellular ligand: analysis of critical residuesD Hollenbaugh, J Bajorath, R Stenkamp, et al.
The Journal of Cell Biology|July 1, 1993
Identification of hyaluronic acid binding sites in the extracellular domain of CD44R J Peach, D Hollenbaugh, I Stamenkovic, et al.
Pageof 5